Kiora Pharmaceuticals (NASDAQ: KPRX) — Perfil da empresa, notícias e dados financeiros
Kiora Pharmaceuticals develops therapeutic solutions for eye diseases, aiming to improve quality of life through innovative research.
Kiora Pharmaceuticals
Kiora Pharmaceuticals (NASDAQ:KPRX) focuses on developing advanced therapeutic solutions aimed at treating eye diseases. Their operations involve extensive research and innovation to address significant unmet needs in ophthalmology. The company's projects are designed to explore novel pathways for treating conditions such as dry eye syndrome, uveitis, and other ocular disorders, with the ultimate objective of improving patients' quality of life. Kiora is dedicated to pushing the boundaries of science to bring forward new, efficacious treatments that can alleviate the burdens of eye diseases on patients worldwide. Their commitment to excellence drives their pursuit of groundbreaking discoveries in the field of eye health.
Resumo
Operações
Produtos e/ou serviços de Kiora Pharmaceuticals
- Development of novel therapeutics for the treatment of ophthalmic diseases, focusing on advanced solutions for eye conditions with significant unmet medical needs.
- Research on innovative drug delivery systems aimed at enhancing the efficacy and safety of treatments for eye diseases.
- Participation in collaborative research projects to explore new pathways for the treatment and prevention of ocular conditions.
- Investment in cutting-edge technology to improve the diagnostic and treatment capabilities for various eye diseases.
- Expansion of a portfolio of products designed to offer comprehensive care for patients suffering from chronic and acute eye health issues.
- Engagement in global partnerships to accelerate the development and distribution of ophthalmic medications in underserved markets.
equipe executiva do Kiora Pharmaceuticals
- Brian M. StremPresident, CEO & Director
- Melissa ToscaChief Financial Officer
- Stefan SperlExecutive Vice President of CMC & Operations
- Keith J. LaneExecutive VP and Head of Clinical Development & Regulatory Affairs
Últimas notícias sobre a Kiora Pharmaceuticals
Principais indicadores financeiros
Resultados divulgados pela Kiora Pharmaceuticals, em USD.
- Cap. de mercado
- 6,7 mi
- Receita (TTM)
- 0
- P/L
- —
- LPA (diluído, TTM)
- -2.5
- Dividend yield
- —
- Margem de lucro
- 0.0%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 0 | -9,5 mi | -10,8 mi | |
| 16 mi | 4,5 mi | 3,6 mi | |
| 0 | -12,6 mi | -12,5 mi | |
| 0 | -12,3 mi | -13,6 mi |